| Literature DB >> 30692983 |
Barney A Geddes1, Marcela A Mendoza-Suárez1, Philip S Poole1.
Abstract
We present a Bacterial Expression Vector Archive (BEVA) for the modular assembly of bacterial vectors compatible with both traditional and Golden Gate cloning, utilizing the Type IIS restriction enzyme Esp3I, and have demonstrated its use for Golden Gate cloning in Escherichia coli. Ideal for synthetic biology and other applications, this modular system allows a rapid, low-cost assembly of new vectors tailored to specific tasks. Using the principles outlined here, new modules (e.g., origin of replication for plasmids in other bacteria) can easily be designed for specific applications. It is hoped that this vector construction system will be expanded by the scientific community over time by creation of novel modules through an open source approach. To demonstrate the potential of the system, three example vectors were constructed and tested. The Golden Gate level 1 vector pOGG024 (pBBR1-based broad-host range and medium copy number) was used for gene expression in laboratory-cultured Rhizobium leguminosarum. The Golden Gate level 1 vector pOGG026 (RK2-based broad-host range, lower copy number and stable in the absence of antibiotic selection) was used to demonstrate bacterial gene expression in nitrogen-fixing nodules on pea plant roots formed by R. leguminosarum. Finally, the level 2 cloning vector pOGG216 (RK2-based broad-host range, medium copy number) was used to construct a dual reporter plasmid expressing green and red fluorescent proteins.Entities:
Keywords: Golden Gate; broad-host range plasmid; cloning vector; modular assembly; open source; shuttle vector
Year: 2019 PMID: 30692983 PMCID: PMC6339899 DOI: 10.3389/fmicb.2018.03345
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Bacterial Expression Vector Archive (BEVA) system for the modular assembly of bacterial vectors. (A) Vector modules are shown in the order they are assembled in a vector construction reaction. Their position in the final construct is labeled. Sequences (5′→ 3′) used to anneal the fragments in order are shown (color-coded) at junctions between modules and remain in the final construct as a scar. (B) Modules at each position. Position 1: cloning sites – Golden Gate level 1 and Golden Gate level 2; position 2: antibiotic resistance – neomycin-, gentamicin- and tetracycline-resistance cassettes; position 3: origins of replication and transfer – RK2 with oriT and pBBR1 with oriT; positions 4–6: accessory modules – par locus for stable plasmid maintenance in the absence of antibiotic selection. Endlinker modules were designed to circularize the plasmid.
Design of modules for vector construction.
| Module | Description of module | Module size (kb) | Cloned module | 5′-side (5′→3′) | 3′-side (5′→3′) |
|---|---|---|---|---|---|
| TGCC | GCAA | ||||
| pLVC-P1-Lv1 | Golden Gate Level 1 cloning site with cloned | 2601 | pOGG004 | ||
| Golden Gate Level 1 cloning site | 2420 | pOGG005 | |||
| pLVC-P1-Lv2 | Golden Gate Level 2 cloning site | 5729 | pOGG006 | ||
| GCAA | ACTA | ||||
| pLVC-P2-neo | Neomycin/kanamycin-resistance | 936 | pOGG008 | ||
| pLVC-P2-gent | Gentamicin-resistance | 813 | pOGG009 | ||
| pLVC-P2-tet | Tetracycline-resistance | 1964 | pOGG042 | ||
| ACTA | TTAC | ||||
| pLVC-P3-RK2 | RK2 (IncP) origin of replication for low copy number plasmid, | 2485 | pOGG010 | ||
| pLVC-P3-pBBR1 | pBBR1 origin of replication for medium copy number plasmid, | 1784 | pOGG011 | ||
| TTAC | CAGA | ||||
| pLVC-P4-par | Partition genes ( | 2408 | pOGG012 | ||
| CAGA | TGTG | ||||
| TGTG | GAGC | ||||
| pLVC-ELT-3 | Endlinker to circularize plasmid after position 3 | 113 | pOGG013 | TTAC | TGCC |
| pLVC-ELT-4 | Endlinker to circularize plasmid after position 4 | 113 | pOGG014 | CAGA | TGCC |
| pLVC-ELT-5 | Endlinker to circularize plasmid after position 5 | 113 | pOGG015 | TGTG | TGCC |
| pLVC-ELT-6 | Endlinker to circularize plasmid after position 6 | 113 | pOGG016 | GAGC | TGCC |
Level 0 modules for cloning in a Level 1 vector.
| Module | Description of module | Module size (bp) | Cloned module | 5′-side (5′ → 3′) | 3′-side (5′ → 3′) |
|---|---|---|---|---|---|
| GGAG | AATG | ||||
| pL0M-PU-pNeo | Promoter upstream of | 386 | pOGG001 | ||
| pL0M-PU-pT7lacO | IPTG-inducible T7RNAP promoter | 95 | pOGG030 | ||
| pL0M-PU-pLac | IPTG-inducible promoter | 258 | pOGG031 | ||
| pL0M-PU-pTau | Taurine-inducible promoter for Alphaproteobacteria | 1811 | pOGG041 | ||
| pL0M-PU-pNifH | Promoter upstream of | 721 | pOGG082 | ||
| AATG | GCTT | ||||
| pL0M-SC-mCherry | Red fluorescence protein mCherry, reporter of gene expression | 716 | EC15071 | ||
| pL0M-SC-sfGFP | Superfolder GFP, stable and bright reporter of gene expression | 722 | pOGG037 | ||
| pL0M-SC-celB | Thermostable beta-galactosidase, reporter of gene expression | 1424 | pOGG050 | ||
| pL0M-SC-gusA | Beta-glucosidase gene, reporter of gene expression | 1817 | pOGG083 | ||
| GCTT | CGCT | ||||
| pL0M-T-pharma | Pharmacia terminator (Invitrogen) | 188 | pOGG003 | ||
| pL0M-T-T7 | Terminator for T7RNAP | 55 | pOGG039 | ||
Strains, plasmids, and primers used in this study.
| Strain, plasmid or primer | Description | Source or reference | Addgene ID |
|---|---|---|---|
| α-Select Gold | Competent cells. Genotype: F – deoR endA1 recA1 relA1 gyrA96 hsdR17(rk-, mk + ) supE44 thi-1 phoA Δ(lacZYA argF)U169 Φ80lacZΔM15λ - | Bioline | |
| DH5α | Competent cells. Genotype: F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ- | Invitrogen | |
| pJP2 | pTR102 GUS with artificial MCS, Ampr Tetr | ||
| EC15071 | pL0M-SC-mCherry. Level 0 SC module cloned in pMS, Spr | ENSA, supplied by Invitrogen | |
| pMS | Vector with ColE1 origin of replication in which modules are supplied from Invitrogen, Spr | Invitrogen | |
| pLMB509 | Highly inducible His tag expression vector, Gmr | 40084 | |
| pOGG001 | pL0M-PU-pNeo, promoter 379 bp upstream from of the start codon of luxC from pIJ11268 of nptII for constitutive gene expression. Level 0 PU module cloned in pMS, Spr | This study | 113978 |
| pOGG003 | pL0M-T-pharma. Level 0 T module cloned in pMS, Spr | Invitrogen | |
| pOGG004 | pLVC-P1-Lv1 (Golden Gate Level 1 cloning site with cloned lacZ) position 1 module for vector construction cloned in pMS, Spr | This study | 113979 |
| pOGG005 | pL1V-Lv1-amp-ColE1, Level 1 cloning vector, high copy number used for protein expression in | This study | 113980 |
| pOGG006 | pLVC-P1-Lv2, Golden Gate Level 2 cloning site, position 1 module for vector construction cloned in pMS, Spr | This study | 113981 |
| pOGG008 | pLVC-P2-neo, neomycin-resistance gene, position 2 module for vector construction cloned in pMS, Spr Nmr/Kanr | This study | 113982 |
| pOGG009 | pLVC-P2-gent, gentamicin-resistance gene, position 2 module for vector construction cloned in pMS, Spr Gmr | This study | 113983 |
| pOGG010 | pLVC-P3-RK2, RK2 origin of replication and oriT from | This study | 113984 |
| pOGG011 | pLVC-P3-pBBR1, pBBR1 origin of replication and oriT from | This study | 113985 |
| pOGG012 | pLVC-P4-par, partition genes (parABCDE from pMS) for plasmid stability, position 4 module for vector construction cloned in pMS, Spr | This study | 113986 |
| pOGG013 | pLVC-ELT-3, connecting position 3 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Spr | This study | 113987 |
| pOGG014 | pLVC-ELT-4, connecting position 4 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Spr | This study | 113988 |
| pOGG015 | pLVC-ELT-5, connecting position 5 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Spr | This study | 113989 |
| pOGG016 | pLVC-ELT-6, connecting position 6 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Spr | This study | 113990 |
| pOGG021 | Destination vector for pL1V-F1, Ampr | ||
| pOGG024 | pL1V-Lv1-gent-pBBR1-ELT3, 3.4 kb, medium copy, broad-host range Level 1 cloning vector, Gmr | This study | 113991 |
| pOGG026 | pL1V-Lv1-neo-RK2-par-ELT4, 6.6 kb, low copy, environmentally stable, broad-host range Level 1 cloning vector, Nmr/Kanr | This study | 113992 |
| pOGG030 | pL0M-PU-pT7lacO, IPTG-inducible T7RNAP promoter 88 bp promoter and RBS driving recombinant protein expression in the pET and pOPIN vectors. Level 0 PU module cloned in pMS, Spr | This study | 113993 |
| pOGG031 | pL0M-PU-pLac, IPTG-inducible promoter 250 bp immediately upstream of the lacZ alpha fragment start codon in pRK415. Level 0 PU module cloned in pMS, Spr | This study | 113994 |
| pOGG037 | pL0M-SC-sfGFP, pMS Level 0 SC module cloned in pMS, Spr | This study | 113995 |
| pOGG039 | pL0M-T-T7. Level 0 T module cloned in pMS, Spr | This study | 113996 |
| pOGG041 | pL0M-PU-pTau, Taurine-inducible promoter for Alphaproteobacteria, Level 0 PU module cloned in pMS, Spr | This study | 113997 |
| pOGG042 | pLVC-P2-tet, tetracycline-resistance gene (tetAR) from pJP2. Made by PCR using oxp0734 and oxp0735 primers in position 2 module for vector construction cloned in pMS, Spr, Tetr | This study | 113998 |
| pOGG050 | pL0M-SC-celB. Level 0 SC module cloned in pMS, Spr | This study | 113999 |
| pOGG054 | Destination vector for pL1V-F2, Ampr | ||
| pOGG056 | Destination vector for Level 2 Endlinker ELB-2, Ampr | ||
| pOGG068 | Destination vector for pL0V-PU, Spr | ||
| pOGG072 | Destination vector for pL0V-SC, Spr | ||
| pOGG082 | pL0M-PU- | This study | 114000 |
| pOGG083 | pL0M-SC-gusA, | This study | 114001 |
| pOGG202 | pL1M-F1-plac (pOGG031), sfGFP (pOGG037) and T-pharma (pOGG003), Ampr | This study | 115503 |
| pOGG203 | pL1M-F2-pNeo (pOGG001), mCherry (EC15071) and T-pharma (pOGG003), Ampr | This study | 115504 |
| pOGG216 | pL2V-L2-tet-pBBR1-ELT3, 9.5 kb, medium copy, broad-host range. Level 2 cloning vector, Tetr | This study | 114002 |
| pOPS0253 | Reporter plasmid constructed with Rlv3841P | This study | 115505 |
| pOPS0254 | Reporter plasmid constructed with Rlv3841P | This study | 115506 |
| pOPS0314 | Reporter Plasmid constructed with constitutive promoter pNeo (pOGG001), | This study | 115507 |
| pOPS0359 | Reporter plasmid constructed with pTau (pOGG041), sfGFP (pOGG037) and T-pharma (pOGG003) assembled in pOGG024, Gmr | This study | 115508 |
| pOPS0377 | Reporter Plasmid constructed with constitutive promoter pNeo (pOGG001), sfGFP (pOGG037) and T-pharma (pOGG003) assembled in pOGG026, Nmr/Kanr | This study | 115509 |
| pOPS0379 | Reporter plasmid constructed with Rlv3841P | This study | 115510 |
| pOSP0750 | Reporter Plasmid constructed with constitutive promoter pNeo (pOGG001) | This study | 115511 |
| pOPS0754 | Dual reporter plasmid. Forward position 1 pOGG202, forward position 2 pOGG203 and level 2 Endlinker ELB-2 (pOGG056) assembled in pOGG216, Tetr | This study | 115512 |
| oxp0376 | Forward primer for amplification of | This study | |
| oxp0377 | Reverse primer for amplification of | This study | |
| oxp0734 | Forward primer for amplification of tetracycline-resistance gene (tetAR) from pJP2. Used in position 2 module for vector construction. Sequence: TTTTGAAGACAAGAATACAGTCATAAGTGCGGC | This study | |
| oxp0735 | Reverse primer for amplification of tetracycline-resistance gene (tetAR) from pJP2. Used in position 2 module for vector construction. Sequence: TTTTTGAAGACAATGCCGGTCTCCATAACCGGA | This study | |
| oxp0474 | Forward primer for amplification of P | This study | |
| oxp0475 | Reverse primer for amplification of P | This study |
Figure 2(A) Schematic map of pOGG024 level 1 broad-host range, medium copy number vector constructed with BEVA for free-living gene expression in laboratory. (B) Schematic map of plasmid pOPS0359 containing a cloned gene sfGFP under the control of a taurine-inducible promoter from Sinorhizobium meliloti in pOGG024. (C–F) Evaluation of pOPS0359 performance as robust free-living gene expression compared to the functionally analogous pLMB509 plasmid. (C,D) Fluorescence detection from GFP expression and (E,F) fitness performance by measurement of OD595 when grown without (0 mM) or with (0.5, 1.0, 10, or 40 mM) taurine. For all graphs, error bars are standard error of the mean (SEM).
Figure 3(A) Schematic map of pOGG026 level 1 broad-host range, lower copy number vector constructed with BEVA for stable environmental gene expression in the absence of antibiotic selection. (B,C) Schematic map of plasmids containing a cloned (B) gusA (pOPS0253) and (C) celB (pOPS0254) under the control of nifH gene promoter (PnifH). (D) Pea nodules formed by Rlv3841[pOPS253] stained with Magenta-glucA. Marker gene gusA is just expressed in nodules. (E) Pea nodules formed by Rlv3841[pOPS254] and (F) bean nodules formed by CIAT899[pOPS254] stained with X-gal after thermal treatment. Marker genes gusA and celB are just expressed in nodules.
Figure 4(A) Schematic map of plasmid pOPS0379 containing sfGFP gene under the control of nifH gene promoter (PnifH). Pea nodules formed by Rlv384[pOPS0379], (B,C) bright-field, (D,E) fluorescence (GFP filter), and (F,G) merged images. GFP expression is observed in the nitrogen-fixing zone.
Figure 5(A) Schematic map of pOGG216 level 2 broad-host range, medium copy number vector constructed with BEVA for multi-gene expression. (B) Schematic map of dual reporter plasmid pOPS0754 which encodes IPTG-inducible sfGFP cloned in Forward Position 1 and constitutively mCherry cloned in Forward Position 2. (C,E,G) Green fluorescence detection (scale, 5,000–31,000). (D,F) Red fluorescence detection (scale, 3,000–29,000 cps). (C,D) Rlv3841 without fluorescence. Rlv3841[pOPS0754] expressing IPTG-inducible sfGFP grown in media (E) containing 0.5 mM IPTG or (G) without IPTG. (F) Rlv3841[pOPS0754] with constitutively expressed mCherry.